Inpatient Smoking Cessation Pilot Program

Tobacco Use Cessation Clinical Trial

Official title:

Smoking Cessation Pilot Program on 9 South

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT05060965
• Other study ID #: IRB00208192
• Status: Withdrawn
• Phase: Early Phase 1
• Start date: October 1, 2019
• Est. completion date: April 2023

Study information

• Verified date: August 2023
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators are implementing a stepwise approach to cessation with a public health focus to improve health outcomes for the investigators' pediatric patients. The investigators are focusing on addressing caregiver smoking as a modifiable risk factor during time of child's hospitalization as a window of opportunity to provide counseling and education to families on secondhand and third hand smoke exposure as well as information on NRT products to heighten caregiver contemplation for quitting. One of the central goals of the investigators' project is to increase immediate access to Nicotine Replacement Therapy (NRT) resources for families during hospitalization which pediatric providers could potentially dose and prescribe to caregivers who are screened positive for smoking. Long-term cessation care is provided by referrals to both the MD Quitline and the John Hopkins Tobacco Treatment Clinic. Both are provided to allow participants options that the participants would find preferable from an insurance and provider perspective.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: April 2023
• Est. primary completion date: April 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Caregivers of patients on an inpatient unit at Johns Hopkins Children's Center who self-identify as tobacco users and wish to initiate tobacco cessation

Exclusion Criteria:

• Pregnant or breast feeding maternal caregivers.

Related Conditions & MeSH terms

• Tobacco Use Cessation

Intervention

Drug:
• Nicotine lozenge
Nicotine replacement therapy
• Nicotine gum
Nicotine replacement therapy
• Nicotine patch
Nicotine replacement therapy

Other:
• Maryland Quitline
Telephone-based tobacco cessation service
• John Hopkins Tobacco Treatment Clinic
Clinic-based tobacco cessation service

Locations

Country	Name	City	State
United States	Johns Hopkins Hospital	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Self-reported attempts to quit smoking	Change in caregiver self-reported tobacco cessation attempt in the past 14-days.	Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
Secondary	Change in Frequency of usage of outpatient tobacco cessation services	Change in frequency of caregiver self-reported usage of outpatient tobacco cessation services (Maryland Quitline or Johns Hopkins Tobacco Treatment Clinic).	Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
Secondary	Change in Usage of nicotine replacement therapy products	Change in caregiver self-reported usage of nicotine replacement therapy in the past 14-days.	Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months